2minutemedicine.com6h
Glucagon-like peptide-1 receptor agonists associated with lower depression risk in older adults with diabetes
In this target trial emulation, glucagon-like peptide-1 receptor agonists (GLP-1RAs) were associated with a lower risk of ...
Study finds GLP-1 receptor agonists target fat over muscle for weight loss
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class ...
Science Daily10h
Genetic evidence that diabetes drug GLP-1 receptor agonists achieve weight loss primarily by reducing fat mass more than muscle
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...
HealthDay on MSN5h
Depression Risk Lower With GLP-1 Receptor Agonists Versus DPP-4 Inhibitors in Seniors
For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associate ...
GlobalData on MSN15h
Semaglutide shortage ends as FDA sets deadline for compounders
With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions of semaglutide are no longer allowed ...
Modern Healthcare5h
Hims & Hers pivots as semaglutide shortage ends
Hims & Hers co-founder and CEO Andrew Dudum said the company will pivot and focus on different offerings such as its ...
“Queer Eye”'s Jonathan Van Ness Shares Dramatic Photos After Weight Loss Drugs Help Him Drop 66 Lbs.
Jonathan Van Ness has made a dramatic transformation since beginning his weight loss journey. On Sunday, Feb. 23, the Queer ...
pharmaphorum17h
Compounders cast adrift after semaglutide shortage ends
The end of the official shortage status for semaglutide came as telehealth company Hims & Hers – which has been pushing sales ...
Jonathan Van Ness Looks Unrecognizable After 66-Lb Weight Loss
Jonathan Van Ness has been on a weight loss journey and he's sharing an update on how things are going so far. The Queer Eye ...
Ozempic could be prescribed to treat depression - as major study shows weight loss jabs boost mental health
The startling findings raise the possibility that the medicines, originally developed to treat diabetes, could one day be ...
Wall Street Thinks This Weight Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk
Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Novo Nordisk stock ...
Inside booming ‘fat jab’ black market as celeb stylist sells meds to Sun reporter for £280 despite deaths linked to drug
WEIGHT-loss drugs can be bought on the black market with no checks or consultation, The Sun has found. We obtained ...